Chinese Robots Begin Restructuring the Global Supply Chain as TIANZHIHANG Attempts Reverse Integration From Surgical Robots to Orthopedic Implants and Overseas Markets

Chinese surgical robot maker TIANZHIHANG said on July 16 it plans to acquire a majority stake in MicroPort Orthopedics.

The deal would expand its business from robot hardware into implants, consumables, and established overseas distribution channels.

It signals a broader shift among Chinese medical robotics firms from domestic hardware substitution to controlling the full commercial stack needed for global competition.

In regulated orthopedic markets such as the US, Europe, and Japan, trust, training, reimbursement, and compliance matter as much as device performance.